Ajanta Pharma P/E Ratio

Current P/E Ratio
32.5
High Valuation
Very High - High growth expectations or significantly overvalued

Ajanta Pharma P/E ratio. Ajanta Pharma (AJANTPHARM) P/E ratio is 32.5 (High), EPS (TTM) ₹84.53, current price ₹3270.30 on NSE vs historical average P/E of 21.47 (90.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Ajanta Pharma share price chart.

Current Valuation Metrics

P/E Ratio 32.5
Current Price ₹3270.30
EPS (TTM) ₹84.53
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 21.47
Historical Range 9.1 - 36.89
Percentile 90.0%

Sector Context

Sector Average 52.27
Sector Median 29.4
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹100.00
Sept 2026 ₹31.07
Mar 2026 ₹21.35

AJANTPHARM P/E Ratio — Valuation Signal & Historical Context

Ajanta Pharma P/E 32.5 vs historical average 21.47, range 9.1–36.89 — signal: Overvalued. Also explore AJANTPHARM stock price history to track price trends across different timeframes.

  • Stock appears overvalued with PE of 32.5, suggesting caution for new investments
  • Current PE is 51.4% above historical average
  • Trading at discount to sector average PE of 52.27

Ajanta Pharma P/E Ratio Historical Trend

AJANTPHARM annual price-to-earnings ratio — 10 years, EPS and year-end price. Current P/E 32.5 vs historical average 21.47. Check AJANTPHARM company valuation to track the company's total market size over time.

AJANTPHARM Historical P/E Ratio — EPS, Year-End Price & Valuation

Ajanta Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 36.89 81.18 ₹2994.35 NSE High
2024 30.2 71.51 ₹2159.65 NSE High
2023 20.73 58.26 ₹1207.75 NSE Moderate
2022 27.31 54.05 ₹1476.15 NSE High
2021 14.53 75.74 ₹1100.70 NSE Low
2020 9.1 71.65 ₹652.30 NSE Low
2019 16.11 48.91 ₹787.80 NSE Moderate
2018 22.32 44.61 ₹995.85 NSE Moderate
2017 21.92 55.48 ₹1215.90 NSE Moderate
2016 15.58 57.0 ₹887.95 NSE Moderate

AJANTPHARM vs Healthcare Peers — P/E Ratio Comparison

Ajanta Pharma P/E 32.5 vs Healthcare average 52.27, median 29.4 — range 2.0–733.0.

Sector Average
52.27
Sector Median
29.4
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low